[3] Foundayo (orforglipron), approved by the FDA on April 1, 2026, changes that calculus
That is the difference between chasing a trend and choosing a treatment, and it is the honest recommendation a medical clinic can stand behind
"So, the reason why we are hearing both the good things and the bad things about these drugs more often is purely because many more people in society are being treated with them," he told the Nolan Show
Hikma and other manufacturers have likewise said they are preparing GLP-1 generics for markets where exclusivities are set to expire starting next year
If you have any questions or aren't sure where to start, our team is on hand to help
Alan Mathis, PharmD Candidate 2013, University of Florida College of Pharmacy The pathophysiology of type-2 diabetes is characterized by insulin resistance and beta-cell dysfunction